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Background
Hypertrophic cardiomyopathy (HCM) is associated with
increased myocardial fibrosis and collagen deposition.
Collagen reduces cardiovascular magnetic resonance
(CMR) derived T2 times, however, the inflammatory
milieu required for its deposition is often associated
with localised oedema. Focal areas of high T2 signal
intensity have been reported in association with areas of
late gadolinium enhancement (LGE) in patients with
HCM. However, this previous work has relied upon the
subjective visual assessment of local changes in signal
intensity. We hypothesised that quantitative CMR T2-
mapping would reveal marked differences in myocardial
T2 characteristics in patients with HCM relative to
controls.
Methods
Twenty-two consecutive patients with HCM (15 male,
age 55.8±8.7 years) but no co-morbidity and 22 healthy
controls (9 male, age 49.3±13.1 years) were studied. For
each subject, a short axis mid-ventricular slice was
acquired using a 1.5T Avanto (Siemens Healthcare,
Erlangen, Germany). A breath-hold T2-prepared single-
shot steady-state free precession (SSFP) sequence was
used to produce three T2-weighted images with different
T2 preparation times (0 ms, 24 ms, 55 ms). Parallel ima-
ging was used to reduce the imaging time and motion-
correction was applied to improve the accuracy of T2
measurement. T2 maps were produced by fitting the sig-
nal intensity-time exponential decay curve using a linear
2-parameter model after logarithmic transformation
(CMRtools, Cardiovascular Imaging Solutions, London,
UK). An inversion recovery prepared gradient echo
sequence with the inversion time optimised to null nor-
mal myocardium was used 10 minutes after intravenous
gadolinium contrast (Gadovist, Bayer-Schering, Berlin,
Germany, 0.1 mmol/kg) to detect late enhancement. Ima-
ging was repeated in an orthogonal phase encoding direc-
tion to exclude artifact.
Results
There were no significant differences in baseline demo-
graphic characteristics between HCM and control
patients. LV-wall thickness, indexed LV mass and ejec-
tion fraction were significantly higher in HCM patients
(Table 1). In keeping with LV hypertrophy, the LV
volumes were significantly smaller. None of the healthy
controls exhibited any late enhancement whereas 18
(82%) HCM patients had areas of mid-wall enhance-
ment, predominantly in the areas of hypertrophy. T2
times in patients with HCM were similar to controls
with no evidence of any significant differences (HCM
54.1±2.5ms versus Controls 54.1±1.6ms, P=0.97).
Conclusions
Quantitative myocardial T2 mapping did not reveal any
evidence of inflammation and was unable to detect the
presence of any oedema in our cohort. Whilst this tech-
nique has been shown to be of utility in other cardio-
myopathies such as dilated cardiomyopathy and
Duchenne muscular dystrophy-associated cardiomyopa-
thy, it does not appear to guide the evaluation of HCM.
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Table 1
Hypertrophic Cardiomyopathy Controls P Value
N 22 22
Male 15 9 NS
Age (years) 55.8±8.7 49.3±13.1 NS
LV-EDV (ml) 138.6±33.0 141.2±32.0 NS
LV ESV (ml) 37.5±14.5 45.0±15.1 NS
Indexed LV-EDV (g/m
2) 68.7±11.2 78.1±12.9 0.02
Indexed LV-ESV (g/m
2) 18.5±6.4 24.7±6.8 0.004
Ejection Fraction (%) 73.5±6.1 68.8±5.5 0.01
LV Mass 185.9±68.2 105.0±30.8 <0.001
Indexed LV Mass (g/m
2) 92.6±33.8 57.8±12.5 <0.001
Maximum Wall Thickness (mm) 18.8±4.9 7.8±1.2 <0.001
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